多発性硬化症 - 暇つぶしWikipedia

多発性硬化症

□記事を途中から表示しています
[最初から表示]

^ De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A (2008). "Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis". Neurology. 70 (13 Part 2): 1113-8. PMID 18272866 doi: ⇒10.1212/01.wnl.0000294325.63006.f8.
^ Bray PF, Bloomer LC, Salmon VC, Bagley MH, Larsen PD (1983). "Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis". Archives of Neurology. 40 (7): 406-8., PMID 6860175,doi:10.1001/archneur.1983.04050070036006.
^ Sumaya CV, Myers LW, Ellison GW (1980). "Epstein-Barr virus antibodies in multiple sclerosis". Archives of Neurology. 37 (2): 94-6. PMID 6243930, doi:10.1001/archneur.1980.00500510052009.
^ Larsen PD, Bloomer LC, Bray PF (1985). "Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis". Neurology. 35 (3): 435-8., PMID 2983262, doi:10.1212/WNL.35.3.435.
^ Lunemann JD, Tintore M, Messmer B, Strowig T, Rovira A, Perkal H, Caballero E, Munz C, Montalban X, Comabella M (2010). "Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis". Annals of Neurology. 67 (2): 159-69., PMC 2848293, PMID 20225269 doi:10.1002/ana.21886.
^ Myhr KM, Riise T, Barrett-Connor E, Myrmel H, Vedeler C, Gronning M, Kalvenes MB, Nyland H (1988). "Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway". Journal of Neurology, Neurosurgery & Psychiatry. 64 (4): 539-42., PMC 2170022 , PMID 9576551.
^ Salvetti M, Giovannoni G, Aloisi F (2009). "Epstein-Barr virus and multiple sclerosis". Current Opinion in Neurology. 22 (3): 201-6., PMID 19359987, doi:10.1097/WCO.0b013e32832b4c8d.
^ Sumaya CV, Myers LW, Ellison GW, Ench Y (1985). "Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis". Annals of Neurology. 17 (4): 371-7., PMID 2988410, doi:10.1002/ana.410170412.
^ Munger KL, Levin LI, O'Reilly EJ, Falk KI, Ascherio A (2011). "Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel". Multiple Sclerosis Journal. 17 (10): 1185-93., PMC 3179777, PMID 21685232, doi:10.1177/1352458511408991.
^ Haahr S, Koch-Henriksen N, Moller-Larsen A, Eriksen LS, Andersen HM (1995). "Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study". Multiple Sclerosis Journal. 1 (2): 73-7., PMID 9345455, doi:10.1177/135245859500100203.
^ Pakpoor J, Disanto G, Gerber JE, Dobson R, Meier UC, Giovannoni G, Ramagopalan SV (2013). "The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis". Multiple Sclerosis Journal. 19 (2): 162-6., PMID 22740437, doi:10.1177/1352458512449682.
^ a b Pender MP (2011). "The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis". The Neuroscientist. 17 (4): 351-67., PMC 3764840, PMID 21075971, doi:10.1177/1073858410381531.
^ Sundqvist E, Sundstrom P, Linden M, Hedstrom AK, Aloisi F, Hillert J, Kockum I, Alfredsson L, Olsson T (2012). "Epstein-Barr virus and multiple sclerosis: interaction with HLA". Genes & Immunity. 13 (1): 14-20. ,PMID 21776012, doi:10.1038/gene.2011.42.
^ Buljevac D, van Doornum GJ, Flach HZ, Groen J, Osterhaus AD, Hop W, van Doorn PA, van der Meche FG, Hintzen RQ (2005). "Epstein-Barr virus and disease activity in multiple sclerosis". Journal of Neurology, Neurosurgery & Psychiatry. 76 (10): 1377-81., PMC 1739347, PMID 16170080, doi:10.1136/jnnp.2004.048504.
^ Haahr S, Plesner AM, Vestergaard BF, Hollsberg P (2004). "A role of late Epstein-Barr virus infection in multiple sclerosis". Acta Neurology Scandinavica. 109 (4): 270-5., PMID 15016009.
^ Munch M, Riisom K, Christensen T, Moller-Larsen A, Haahr S (1998). "The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients?". Acta Neurology Scandinavica. 97 (3): 171-4., PMID 9531433.
^ Hollsberg P, Hansen HJ, Haahr S (2003). "Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis". Clinical & Experimental Immunology. 132 (1): 137-43., PMC 1808679, PMID 12653848, doi:10.1046/j.1365-2249.2003.02114.x.
^ Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B, Stadelmann C, Gattenlohner S, Owens GP, Gilden D, Bennett JL (2010). "Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis". Neurology. 74 (14): 1127-35., PMC 2865779 PMID 20220124, doi:10.1212/WNL.0b013e3181d865a1.
^ Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS, Roughan JE, Almendinger SE, Blewett MM, Bruck W, Hafler DA, O'Connor KC (2009). "Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain". Brain. 132 (Pt 12): 3318-28., PMC 2792367, PMID 19638446, doi:10.1093/brain/awp200.

次ページ

記事の検索

Size:119 KB
出典: フリー百科事典『ウィキペディア（Wikipedia）』
担当:undef